Highest precision in the capture of health data –
seca and Masimo announce partnership
Conventional pulse oximetry assumes that arterial blood is the only blood moving (pulsating) in the measurement site. During patient motion, the venous blood also moves, which causes conventional pulse oximetry to under-read because it cannot distinguish between arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it and, by using adaptive filters, cancels the noise and extracts the arterial signal. It then reports the true arterial oxygen saturation and pulse rate. Masimo SET is a breakthrough technology that represents a new and fundamentally distinct method of acquiring, processing and reporting arterial oxygen saturation and pulse rate. Masimo SET greatly enhances the accuracy of SpO2 monitoring, particularly in the most difficult patient conditions such as motion and low peripheral perfusion. Furthermore, clinical studies have demonstrated that the use of Masimo SET, in conjunction with Masimo’s sensors, significantly reduces the cost of care.
Robert Vogel, Managing Director for Sales & Marketing at seca: "All our products and system solutions are developed to simplify work processes and ensure outstanding precision in the interest of patient safety. We work with only the best players in the market and welcome the chance to work with Masimo, a world market leader that shares our quality standards and also delivers the best measurement results even under difficult conditions.
"Jon Coleman, Masimo’s President of World Wide Sales and OEM Business said, “seca is a recognized global leader in medical measuring systems and scales. Combining best-in-class measurement technologies that provide superior performance, accuracy and affordability, supports our organizations' mutual vision of offering solutions that help clinicians improve patient outcomes and reduce the cost of healthcare delivery. We are very pleased to partner with seca to bring Masimo’s superior Measure-through-Motion and Low Perfusion pulse oximetry performance to seca’s vast base of caregivers and their patients.”
More information at www.seca.com and www.masimo.com.
seca gmbh & co. kg
Anika Otto, PR-Manager
Tel.: +49 40 20 00 00 411
seca – precision for health
Since 1840 seca has perfected the skill of developing innovative weighing technology combined with practical functions and has become the world's market leader in medical measuring and weighing. seca measuring systems and scales are sold by 14 branch offices and exported to 110 countries. The seca service network guarantees continuous maintenance of the precision instruments. To provide doctors and medical personnel with professional support, seca maintains close contact to users and tailors innovative products to the exact needs of their medical applications. Examples include networked measuring stations that communicate with each other, service and software systems that simplify medical routines and the medical Body Composition Analyzer (mBCA) which uses Bioelectrical Impedance Measurement (BIA) to revolutionize diagnostics and treatment. Ultra-modern production technology, durable materials and a worldwide quality management system ensure top-level product standards.
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® noninvasive and continuous total hemoglobin (SpHb®), acoustic respiration rate (RRa ®), Masimo Patient SafetyNet™, SedLine® (EEG-based) Brain Function Monitors, and capnography monitors.
1 FDA approval pending